| scholarly article | Q13442814 |
| P50 | author | Guohong Hu | Q56885745 |
| P2093 | author name string | Qing Wei | |
| Rong Lei | |||
| P2860 | cites work | Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states | Q21260380 |
| The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 | Q24608778 | ||
| Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells | Q24649127 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
| CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members | Q28201693 | ||
| The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination | Q28201717 | ||
| The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2 | Q28216784 | ||
| The emerging roles of forkhead box (Fox) proteins in cancer | Q28253741 | ||
| Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma | Q28254781 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival | Q30499382 | ||
| A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer | Q33634277 | ||
| FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice | Q33645103 | ||
| FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts | Q33646924 | ||
| MicroRNA-183 family members regulate sensorineural fates in the inner ear. | Q33766505 | ||
| Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer | Q33837404 | ||
| Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients | Q39016698 | ||
| Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. | Q39183046 | ||
| MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells | Q39203769 | ||
| Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. | Q39207993 | ||
| miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. | Q39376671 | ||
| Identification of a new microRNA expression profile as a potential cancer screening tool | Q39718497 | ||
| NDRG1 is necessary for p53-dependent apoptosis | Q40514046 | ||
| Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value | Q43754665 | ||
| MicroRNA expression differentiates between primary lung tumors and metastases to the lung | Q43819523 | ||
| MicroRNA gene expression in the mouse inner ear. | Q46189877 | ||
| Efficient in vivo microRNA targeting of liver metastasis | Q46584676 | ||
| MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster | Q48123763 | ||
| Hsa-mir-182 downregulates RASA1 and suppresses lung squamous cell carcinoma cell proliferation. | Q51750077 | ||
| Expression patterns of miR-96, miR-182 and miR-183 in the development inner ear. | Q51930428 | ||
| The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. | Q52901064 | ||
| Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. | Q53299649 | ||
| Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. | Q54223185 | ||
| Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control | Q81546531 | ||
| MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma | Q83424020 | ||
| MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer | Q84274804 | ||
| MicroRNA expression signatures of bladder cancer revealed by deep sequencing | Q33862587 | ||
| Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer | Q33894047 | ||
| miR-182 as a prognostic marker for glioma progression and patient survival. | Q33947151 | ||
| miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells | Q34064071 | ||
| MicroRNA alterations of pancreatic intraepithelial neoplasias | Q34082610 | ||
| Identification of microRNAs controlling human ovarian cell proliferation and apoptosis | Q34090285 | ||
| miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors | Q34157084 | ||
| Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance | Q34211457 | ||
| MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. | Q34253391 | ||
| microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer | Q34312916 | ||
| MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer | Q34423582 | ||
| Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer | Q34489344 | ||
| Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer | Q34506226 | ||
| MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer | Q34576641 | ||
| The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. | Q34592812 | ||
| Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1). | Q34852248 | ||
| Inhibition of proliferation and induction of autophagy by atorvastatin in PC3 prostate cancer cells correlate with downregulation of Bcl2 and upregulation of miR-182 and p21. | Q34925849 | ||
| Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. | Q34976152 | ||
| Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation | Q34984714 | ||
| Stage and tissue-specific prognostic impact of miR-182 in NSCLC. | Q35103842 | ||
| Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins | Q35264079 | ||
| Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model | Q35740574 | ||
| TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. | Q36659217 | ||
| MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. | Q36685274 | ||
| Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor | Q37081286 | ||
| Targeted deletion of miR-182, an abundant retinal microRNA | Q37124168 | ||
| miRNA profiling along tumour progression in ovarian carcinoma | Q37295492 | ||
| Alterations in expression profile of iron-related genes in colorectal cancer | Q37298710 | ||
| Higher expression of circulating miR-182 as a novel biomarker for breast cancer | Q37326193 | ||
| CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes | Q37448141 | ||
| Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells. | Q37631794 | ||
| Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues | Q38116249 | ||
| Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? | Q38312446 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2-9 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Thoracic Cancer | Q26842004 |
| P1476 | title | Roles of miR-182 in sensory organ development and cancer | |
| P478 | volume | 6 |
| Q38859488 | Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review) |
| Q40178952 | Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. |
| Q42315442 | Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection |
| Q91891000 | DNA methylation directs microRNA biogenesis in mammalian cells |
| Q58107147 | Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex |
| Q41841045 | Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells |
| Q36069168 | Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions |
| Q58798829 | Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling |
| Q33688638 | Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions. |
| Q54089797 | MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer. |
| Q92450911 | MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip |
| Q37744933 | MiRNA182 regulates percentage of myeloid and erythroid cells in chronic myeloid leukemia |
| Q28076427 | MicroRNA-183 Family in Inner Ear: Hair Cell Development and Deafness |
| Q47699114 | MicroRNAs are potential objective and early biomarkers for acute rejection of transplanted limbs in a rat model. |
| Q90287073 | PIWIL-2 and piRNAs are regularly expressed in epithelia of the skin and their expression is related to differentiation |
| Q38752093 | Posttranscriptional regulation of FOXO expression: microRNAs and beyond |
| Q47380817 | Protection of macrophages from intracellular pathogens by miR-182-5p mimic-a gene expression meta-analysis approach |
| Q100750569 | RNA in cancer |
| Q41143010 | Relationship between miR-21 and miR-182 levels in peripheral blood and gastric cancer tissue |
| Q92145004 | Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma |
| Q92723066 | Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer |
| Q35968088 | Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury |
| Q58694197 | The Network of Non-coding RNAs in Cancer Drug Resistance |
| Q38936321 | The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. |
| Q46488114 | The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis |
| Q47629674 | miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma |
| Q38986337 | miR-182 Regulates Slit2-Mediated Axon Guidance by Modulating the Local Translation of a Specific mRNA. |
| Q33873856 | miR-182 aids in receptive endometrium development in dairy goats by down-regulating PTN expression |
| Q89170829 | miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells |
| Q47856700 | miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer. |
Search more.